Replimune Group, Inc.
(REPL - NASDAQ)
13,02 USD
📋 Profilo Aziendale

Replimune Group, Inc. is a biotechnology enterprise dedicated to pioneering oncolytic immuno-gene therapies aimed at treating various cancers.

|